Cargando…
Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).
Monoclonal antibody MR6 detects gp200-MR6, a molecule functionally associated with the interleukin 4 (IL- 4) receptor. Positive immunolabeling with MAb MR6 was obtained in 28/28 transitional cell carcinomas of the bladder, representing a range of different grades and stages of disease, as well as in...
Autores principales: | Tungekar, M. F., Gatter, K. C., Ritter, M. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074450/ https://www.ncbi.nlm.nih.gov/pubmed/8595155 |
Ejemplares similares
-
Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.
por: Kaklamanis, L., et al.
Publicado: (1996) -
Biopsies of the normal-appearing urothelium in primary bladder cancer
por: Librenjak, Davor, et al.
Publicado: (2010) -
Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast.
por: al-Tubuly, A. A., et al.
Publicado: (1996) -
Signalling Molecules in the Urothelium
por: Winder, Michael, et al.
Publicado: (2014) -
Immunohistochemistry as a paramount tool in research of normal urothelium, bladder cancer and bladder pain syndrome
por: Zupančič, Daša, et al.
Publicado: (2021)